Description

Draflazine is a high-purity chemical compound, identified by CAS NO 120770-34-5, that serves as a critical intermediate in advanced pharmaceutical research and development. Its primary value lies in its role as a selective adenosine A1 receptor antagonist, making it a key building block for investigating cardiovascular and neurological pathways. This compound is essential for pharmaceutical companies, research institutions, and contract development and manufacturing organizations (CDMOs) focused on creating novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of investigational drugs targeting adenosine receptors.
• Cardiovascular Research: Used in preclinical studies to explore compounds for heart rate regulation and cardioprotective effects.
• Neurological Research: Employed in the development of potential treatments for conditions like Parkinson's disease and sleep disorders.
• Biochemical Assay Standard: Serves as a reference standard in high-throughput screening and receptor binding assays.
• Academic Research: Utilized in university and institutional labs for pharmacological studies and mechanism-of-action research.
• Process Development: Acts as a model compound for optimizing synthetic routes and scaling up production in pilot plants.

Basic Information

Product Name	Draflazine
CAS No.	120770-34-5
Molecular Formula	C19H25N5O2
Molecular Weight	355.44 g/mol
Synonyms	Draflazine; 8-Cyclopentyl-3-(3-fluorobenzyl)-1-propyl-3,7-dihydro-1H-purine-2,6-dione; 1-Propyl-8-cyclopentyl-3-(3-fluorobenzyl)xanthine; L-156,602; L 156602; L156602; Adenosine A1 Receptor Antagonist L-156,602
EINECS	Contact for details

Quality Control

Our Draflazine is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and rigorous control of residual solvents and impurities. We provide full traceability and Certificates of Analysis (COA) are available for every shipment, ensuring compliance with the stringent requirements of research and pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a desiccated environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.